Chitosan as a Novel Nasal Delivery System for Peptide Drugs

A nasal solution formulation of the cationic material chitosan was shown to greatly enhance the absorption of insulin across the nasal mucosa of rat and sheep. The absorption promoting effect was concentration dependent with the optimal efficacy obtained for concentrations higher than 0.2% and 0.5% in rats and sheep, respectively. The absorption promoting effect was reversible with time in a “pulse-chase” study. Histological examination of the nasal mucosa of rats exposed to a chitosan solution for 60 minutes showed little change.

[1]  M. Takada,et al.  Sustained-release and intragastric-floating granules of indomethacin using chitosan in rabbits. , 1988, Chemical & pharmaceutical bulletin.

[2]  Claus-Michael Lehr,et al.  In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers , 1992 .

[3]  H. Saitǒ,et al.  Interaction of indomethacin with low molecular weight chitosan, and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans , 1991 .

[4]  T. Nagai,et al.  Use of chitosan for sustained-release preparations of water-soluble drugs. , 1982, Chemical & pharmaceutical bulletin.

[5]  S. Davis,et al.  Investigation of the nasal absorption of biosynthetic human growth hormone in sheep—use of a bioadhesive microsphere delivery system , 1990 .

[6]  T. Masada,et al.  Effect of interpolymer complex formation on bioadhesive property and drug release phenomenon of compressed tablet consisting of chitosan and sodium hyaluronate. , 1990, Chemical & pharmaceutical bulletin.

[7]  Hans Bisgaard,et al.  Bioadhesive microspheres as a potential nasal drug delivery system , 1987 .

[8]  Lisbeth Illum,et al.  Nasal administration of insulin using bioadhesive microspheres as a delivery system , 1990 .

[9]  L. Illum,et al.  Absorption of peptides and proteins from the respiratory tract and the potential for development of locally administered vaccine. , 1990, Critical reviews in therapeutic drug carrier systems.

[10]  S. Davis,et al.  Nasal administration of gentamicin using a novel microsphere delivery system , 1988 .

[11]  T. Nadai,et al.  The use of chitin and chitosan as drug carriers. , 1981, Chemical & pharmaceutical bulletin.

[12]  A. Taylor,et al.  Charge selectivity of rat intestinal capillaries. Influence of polycations. , 1986, Gastroenterology.

[13]  T. Nagai,et al.  Directly compressed tablets containing chitin or chitosan in addition to mannitol. , 1982, Chemical & pharmaceutical bulletin.

[14]  L. Illum,et al.  Nasal absorption in the rat. I: A method to demonstrate the histological effects of nasal formulations , 1991 .

[15]  Y. Takatsuka,et al.  Mechanisms for the enhancement of the nasal absorption of insulin by surfactants , 1981 .

[16]  S. Davis,et al.  Intranasal Insulin , 1992, Clinical pharmacokinetics.

[17]  P. Edman,et al.  Microspheres as a nasal delivery system for peptide drugs , 1992 .